ALNYLAM PHARMACEUTICALS, INC. Insider Trading Activity Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ALNYLAM PHARMACEUTICALS, INC. Insider Trading Activity Insider Trading Activity
Updated Aug 22, 2024
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alnylam Pharmaceuticals, Inc.
|
0
|
$182.50 | -$2,925,000.00 |
—
| 73.44K |
Aug 20
|
Scheduled
| ||||||
Alnylam Pharmaceuticals, Inc.
| -1.30K |
$180.04 | -$4,122,086.36 | -9.17% | 12.88K | +1 |
Aug 12
|
Scheduled
| |||||
Alnylam Pharmaceuticals, Inc.
|
0
|
$190.84 | -$2,882,133.97 |
—
| 136 |
Aug 6
|
Scheduled
| ||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
$177.50 | -$2,802,380.00 |
—
| 73.44K |
Aug 1
|
Scheduled
| ||||||
Alnylam Pharmaceuticals, Inc.
| -7.09K |
$261.00 | -$1,851,273.00 | -8.81% | 73.44K |
Jul 11
|
Scheduled
| ||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
$185.61 | -$924,715.00 |
—
| 8.44K |
Jun 25
|
Scheduled
| ||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
$150.73 | -$4,540,748.70 |
—
| 136 |
Jun 24
|
Scheduled
| ||||||
Alnylam Pharmaceuticals, Inc.
| 2.19K |
$230.99 | -$485,773.38 | +16.34% | 15.61K |
Jun 24 - Jun 25
| |||||||
Alnylam Pharmaceuticals, Inc.
| 8.65K |
$230.99 | -$1,917,475.08 | +12.04% | 80.53K |
Jun 24 - Jun 25
| |||||||
Alnylam Pharmaceuticals, Inc.
| 1.67K |
$231.00 | -$370,747.09 | +6.15% | 28.89K | +1 |
Jun 24 - Jun 25
| ||||||
Alnylam Pharmaceuticals, Inc.
| 1.67K |
$231.00 | -$370,747.09 | +16.75% | 11.66K | +1 |
Jun 24 - Jun 25
| ||||||
Alnylam Pharmaceuticals, Inc.
| 1.3K |
$230.99 | -$276,730.75 | +10.09% | 14.18K | +1 |
Jun 24 - Jun 25
| ||||||
Alnylam Pharmaceuticals, Inc.
| 8.3K |
$107.72 | -$1,219,646.17 | +6,102.94% | 8.44K |
May 29
|
Scheduled
| ||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 16
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 16
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 16
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 16
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 16
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 16
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 16
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 16
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 16
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 16
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
|
May 16
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
—
|
—
|
—
|
0
| +1 | |||||||
Alnylam Pharmaceuticals, Inc.
| 4.75K |
—
|
—
| +90.74% | 9.99K | +1 |
Mar 1
| ||||||
Alnylam Pharmaceuticals, Inc.
| 4.75K |
—
|
—
| +54.82% | 13.42K |
Mar 1
| |||||||
Alnylam Pharmaceuticals, Inc.
| 7.74K |
—
|
—
| +39.74% | 27.22K | +1 |
Mar 1
| ||||||
Alnylam Pharmaceuticals, Inc.
| 23.75K |
—
|
—
| +49.36% | 71.88K |
Mar 1
| |||||||
Alnylam Pharmaceuticals, Inc.
|
0
|
$105.30 | -$2,762,570.94 |
—
|
0
|
Feb 29
|
Scheduled
| ||||||
Alnylam Pharmaceuticals, Inc.
| 1.17K |
$155.30 | -$77,805.43 | +28.65% | 5.24K | +1 |
Feb 27 - Feb 28
| ||||||
Alnylam Pharmaceuticals, Inc.
| 1.33K |
$155.30 | -$89,144.57 | +7.35% | 19.48K | +1 |
Feb 27 - Feb 28
| ||||||
Alnylam Pharmaceuticals, Inc.
| 2.99K |
$155.31 | -$455,357.07 | +6.62% | 48.13K |
Feb 27 - Feb 28
| |||||||
Alnylam Pharmaceuticals, Inc.
| 1.33K |
$155.30 | -$89,144.57 | +18.19% | 8.67K |
Feb 27 - Feb 28
| |||||||
Alnylam Pharmaceuticals, Inc.
| 549 |
$155.30 | -$51,094.50 | +15.32% | 4.13K | +1 |
Feb 27 - Feb 28
| ||||||
Alnylam Pharmaceuticals, Inc.
| 2.99K |
$148.06 | -$193,665.96 | +68.75% | 7.33K |
Feb 15 - Feb 16
| |||||||
Alnylam Pharmaceuticals, Inc.
| 2.27K |
$148.06 | -$149,099.42 | +14.31% | 18.14K | +1 |
Feb 15 - Feb 16
| ||||||
Alnylam Pharmaceuticals, Inc.
| 2.27K |
$148.06 | -$149,396.69 | +125.99% | 4.07K | +1 |
Feb 15 - Feb 16
| ||||||
Alnylam Pharmaceuticals, Inc.
| 9.92K |
$148.06 | -$1,040,884.56 | +28.18% | 45.14K |
Feb 15 - Feb 16
| |||||||
Alnylam Pharmaceuticals, Inc.
| 3.58K |
$170.99 | -$272,050.04 |
∞
| 3.58K | +1 |
Feb 1 - Feb 2
| ||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.